BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VTIMEZONE
TZID:Pacific Standard Time
X-LIC-LOCATION:America/Los_Angeles
BEGIN:STANDARD
DTSTART:20241103T020000
RRULE:FREQ=YEARLY;BYDAY=1SU;BYMONTH=11
TZNAME:PST
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20250309T020000
RRULE:FREQ=YEARLY;BYDAY=2SU;BYMONTH=3
TZNAME:PDT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DESCRIPTION:2022 Summer Conference by the ºÃÉ«ÏÈÉú\n\
 nTitle: Industry Therapeutic Update from argenx: Innovation in Anti-AChR 
 Antibody Positive gMG Treatment for Adults: Clinical Data of VYVGART® in 
 the Pivotal ADAPT Trial\n\nAccess URL: /MSA/Public/Eve
 nts/GetEventURL/15186\n\nLearn More About This Event: 
 /MSA/Public/Events/Details/15186
DTEND;TZID=Pacific Standard Time:20220716T074500
DTSTAMP:20260405T184959Z
DTSTART;TZID=Pacific Standard Time:20220716T063000
LOCATION:/MSA/Public/Events/GetEventURL/15186
SEQUENCE:0
SUMMARY:AAN: Industry Therapeutic Update from argenx: Innovation in Anti-A
 ChR Antibody Positive gMG Treatment for Adults: Clinical Data of VYVGART®
  in the Pivotal ADAPT Trial
UID:7bb6177e-9fb7-432d-8db6-e88485079bdd
END:VEVENT
END:VCALENDAR